Literature DB >> 1531041

The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules.

A M Wegener1, F Letourneur, A Hoeveler, T Brocker, F Luton, B Malissen.   

Abstract

Recent studies have demonstrated that the CD3-zeta subunit of the T cell antigen receptor (TCR) complex is involved in signal transduction. However, the function of the remaining invariant subunits, CD3-gamma, -delta, and epsilon, is still poorly understood. To examine their role in TCR function, we have constructed TCR/CD3 complexes devoid of functional zeta subunit and showed that they are still able to trigger the production of interleukin-2 in response to antigen or superantigen. These data, together with previous results, indicate that the TCR/CD3 complex is composed of at least two parallel transducing units, made of the gamma delta epsilon and zeta chains, respectively. Furthermore, the analysis of partially truncated zeta chains has led us to individualize a functional domain that may have constituted the building block of most of the transducing subunits associated with antigen receptors and some Fc receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531041     DOI: 10.1016/0092-8674(92)90208-t

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  105 in total

Review 1.  Regulation of integrin function by T cell activation: points of convergence and divergence.

Authors:  T Zell; W J Kivens; S A Kellermann; Y Shimizu
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations.

Authors:  J C Zong; D M Ciufo; D J Alcendor; X Wan; J Nicholas; P J Browning; P L Rady; S K Tyring; J M Orenstein; C S Rabkin; I J Su; K F Powell; M Croxson; K E Foreman; B J Nickoloff; S Alkan; G S Hayward
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  CD3-epsilon overexpressed in prothymocytes acts as an oncogene.

Authors:  B Wang; J She; M Salio; D Allen; E Lacy; N Lonberg; C Terhorst
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

4.  CD3 and CD2 antigen-mediated CD3 gamma-chain phosphorylation in permeabilized human T cells. Regulation by cytosolic phosphatases.

Authors:  D R Alexander; M H Brown; A L Tutt; M J Crumpton; E Shivnan
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

5.  Targeting of the T-cell receptor zeta-chain gene in embryonic stem cells: strategies for generating multiple mutations in a single gene.

Authors:  P E Love; M L Tremblay; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

6.  p59fyn tyrosine kinase associates with multiple T-cell receptor subunits through its unique amino-terminal domain.

Authors:  L K Timson Gauen; A N Kong; L E Samelson; A S Shaw
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

Review 7.  The B cell antigen receptor complex: mechanisms and implications of tyrosine kinase activation.

Authors:  J Tseng; Y J Lee; B J Eisfelder; M R Clark
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

8.  Influence of MHC class I molecules on T-cell proliferation induced by CD3 or Thy-1 stimulation.

Authors:  N Amirayan; E Furrie; F Deleuil; A Mellor; L Leserman; P Machy
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

9.  Engineering higher affinity T cell receptors using a T cell display system.

Authors:  Adam S Chervin; David H Aggen; John M Raseman; David M Kranz
Journal:  J Immunol Methods       Date:  2008-10-12       Impact factor: 2.303

10.  Constitutive tyrosine phosphorylation of the T-cell receptor (TCR) zeta subunit: regulation of TCR-associated protein tyrosine kinase activity by TCR zeta.

Authors:  N S van Oers; W Tao; J D Watts; P Johnson; R Aebersold; H S Teh
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.